2,2-二甲基丙酸3-(2-氯-6-甲基氨基嘌呤-9-基)-2-(2,2-二甲基-丙酰氧基甲基)-丙酯
2,2-二甲基丙酸3-(2-氯-6-甲基氨基嘌呤-9-基)-2-(2,2-二甲基-丙酰氧基甲基)-丙酯结构式
|
常用名 | 2,2-二甲基丙酸3-(2-氯-6-甲基氨基嘌呤-9-基)-2-(2,2-二甲基-丙酰氧基甲基)-丙酯 | 英文名 | MRS 2395 |
|---|---|---|---|---|
| CAS号 | 491611-55-3 | 分子量 | 439.93600 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C20H30ClN5O4 | 熔点 | N/A | |
| MSDS | 中文版 | 闪点 | N/A |
|
Acyclic analogues of adenosine bisphosphates as P2Y receptor antagonists: phosphate substitution leads to multiple pathways of inhibition of platelet aggregation.
J. Med. Chem. 45 , 5694-5709, (2002) Activation by ADP of both P2Y(1) and P2Y(12) receptors in platelets contributes to platelet aggregation, and antagonists at these receptor subtypes have antithrombotic properties. In an earlier publication, we have characterized the SAR as P2Y(1) receptor ant... |
期刊文献综述：
更多...